EP 0858466 A1 19980819 - USE OF PROTEIN GAX FOR TREATING CANCER
Title (en)
USE OF PROTEIN GAX FOR TREATING CANCER
Title (de)
VERWENDUNG DES GAX-PROTEINS ZUR KREBSTHERAPIE
Title (fr)
APPLICATION DE LA PROTEINE GAX AU TRAITEMENT DE CANCERS
Publication
Application
Priority
- FR 9601690 W 19961028
- FR 9512871 A 19951031
Abstract (en)
[origin: WO9716459A1] The therapeutical use, particularly in cancer treatment, of a nu leic acid coding for all or part of protein GAX or a variant thereof, is disclosed.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 35/76 (2006.01); A61K 38/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C12N 15/09 (2006.01); C12N 15/00 (2006.01); C12N 15/861 (2006.01); C12R 1/92 (2006.01)
CPC (source: EP KR)
A61K 38/17 (2013.01 - KR); A61P 35/00 (2018.01 - EP); C07K 14/47 (2013.01 - KR); C07K 14/4703 (2013.01 - EP); C12N 15/86 (2013.01 - EP); A61K 38/00 (2013.01 - EP); C12N 2710/10343 (2013.01 - EP); C12N 2810/10 (2013.01 - EP); C12N 2810/40 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9716459 A1 19970509; AU 730324 B2 20010301; AU 7498296 A 19970522; BR 9611206 A 19990330; CA 2233250 A1 19970509; CZ 131598 A3 19980812; EP 0858466 A1 19980819; FR 2740344 A1 19970430; FR 2740344 B1 19971121; HU P9900011 A2 19990428; HU P9900011 A3 19991129; JP H11514881 A 19991221; KR 19990067174 A 19990816; NO 981822 D0 19980423; NO 981822 L 19980423; SK 56198 A3 19981104; ZA 969147 B 19970527
DOCDB simple family (application)
FR 9601690 W 19961028; AU 7498296 A 19961028; BR 9611206 A 19961028; CA 2233250 A 19961028; CZ 131598 A 19961028; EP 96937351 A 19961028; FR 9512871 A 19951031; HU P9900011 A 19961028; JP 51711097 A 19961028; KR 19980703125 A 19980429; NO 981822 A 19980423; SK 56198 A 19961028; ZA 969147 A 19961030